🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study has 2 parts. The main aim of Part 1 is to check for side effect...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2021-11-12
Trial ID
NCT05020015
Treatments Being Tested
To learn if adding a healthy person's natural killer (NK) cells to the comb...
Status
Recruiting
Location
Case Western Reserve University
Start Date
2023-10-26
Trial ID
NCT05834244
Treatments Being Tested
This study is a Phase 1 / 2 trial to determine the safety and efficacy of C...
Status
Terminated
Location
UC Irvine
Start Date
2020-09-02
Trial ID
NCT04365101
Treatments Being Tested
Gastrointestinal (GI) cancers account for the most common cancers. Despite ...
Status
Completed
Location
University hospital of Besançon
Start Date
2009-11
Trial ID
NCT02845999
RATIONALE: Giving low doses of chemotherapy, such as busulfan and fludarabi...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2011-01-07
Trial ID
NCT00448201
This study is being done to determine the highest tolerated dose of an inve...
Status
Completed
Location
Fred Hutch/University of Washington Medical Center
Start Date
2021-08-01
Trial ID
NCT04900454
Treatments Being Tested
This is a single-arm, open-label, multi-center, Phase 1 study to determine ...
Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute
Start Date
2020-09-21
Trial ID
NCT04623944
Treatments Being Tested
This is a phase I study. The purpose of this study is to see if it is safe ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-01-05
Trial ID
NCT02650648
Treatments Being Tested
Primary objective: * To determine the safety of adback T- or Natural Kille...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-09
Trial ID
NCT00536978
This is a multi-institutional Phase I/II study of an allogeneic KIR-HLA mis...
Status
Recruiting
Location
Mark Juckett, MD
Start Date
2026-05-08
Trial ID
NCT07591649
Treatments Being Tested